AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 193 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $700,920 | +106.2% | 20,346 | 0.0% | 0.01% | +100.0% |
| Q2 2020 | $339,982 | +15.9% | 20,346 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $293,389 | -56.9% | 20,346 | 0.0% | 0.00% | -42.9% |
| Q4 2019 | $680,981 | +59.8% | 20,346 | 0.0% | 0.01% | +40.0% |
| Q3 2019 | $426,045 | +0.6% | 20,346 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $423,604 | -6.8% | 20,346 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $454,733 | -6.6% | 20,346 | 0.0% | 0.01% | -16.7% |
| Q4 2018 | $486,676 | -12.3% | 20,346 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $555,039 | +1.5% | 20,346 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $547,000 | +0.6% | 20,346 | +19.1% | 0.01% | 0.0% |
| Q1 2018 | $544,000 | -15.8% | 17,085 | 0.0% | 0.01% | -14.3% |
| Q4 2017 | $646,000 | – | 17,085 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,295,712 | $47,524,000 | 3.98% |
| Samsara BioCapital, LLC | 232,571 | $3,354,000 | 1.93% |
| Eventide Asset Management | 3,851,000 | $55,531,000 | 1.80% |
| Burrage Capital Management LLC | 112,546 | $1,609,000 | 1.58% |
| Avidity Partners Management LP | 408,000 | $5,883,000 | 0.81% |
| RICE HALL JAMES & ASSOCIATES, LLC | 982,484 | $14,167,000 | 0.79% |
| Bullseye Asset Management LLC | 43,374 | $626,000 | 0.75% |
| Nantahala Capital Management | 1,005,302 | $14,496,000 | 0.54% |
| ARMISTICE CAPITAL, LLC | 600,000 | $8,652,000 | 0.54% |
| Values First Advisors, Inc. | 27,042 | $389,947 | 0.47% |